Home > Analytics > POLY MEDICURE

POLY MEDICURE
Intrinsic Value | Fundamental Analysis

BOM : 531768     NSE : POLYMED    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Average
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Mar 22,2023
Price(EOD): ₹ 969.85
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Medical Equipment/Supplies/Accessories
MCap: ₹ 9,310.56 Cr
Value of ₹ 1 Lac invested in POLY MEDICURE
on Mar 22,2018 (price: ₹ 250.90)

₹ 1 L

₹ 3.87 L

1W : -0.2% 1M : 5% 1Y : 12.5%
COMMUNITY POLL
for POLY MEDICURE
Please provide your vote to see the results
POLY MEDICURE is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
POLY MEDICURE -0.2% 5% 12.5%


No other companies found in this Industry

FUNDAMENTAL ANALYSIS OF POLY MEDICURE

 
Fundamentals Score
[ Q(TTM): Dec2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 POLYMED is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF POLY MEDICURE

 
Valuation Score
[As on : Mar 22,2023 ]

Ratio Consolidated
P/E
P/B
P/S
60.04
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 155.02 Cr
[Latest Qtr - Dec2022 - Consolidated Results ]

8.57
P/B Calculated based on Book Value of Rs 1,085.96 Cr
[Latest Year - Mar2022 - Consolidated Results ]

8.73
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,065.89 Cr
[Latest Qtr - Dec2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 31% undervalued companies ! Discover More →

FAIR VALUE OF POLY MEDICURE

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
237%
203%
209%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF POLY MEDICURE


Insights 💡 POLYMED is one of the top 10% companies with bullish price momentum currently! Discover More →

POLY MEDICURE vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF POLY MEDICURE

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.1
0.13
0.44
0.22
0.12
0.14
0.47
0.24
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF POLY MEDICURE

Pledged Promoter Shares
0 %
As on : Dec2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF POLY MEDICURE

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
3.69%
9.79%
13.23%
15.69%
23.71%
38.84%
46.62%
46.11%
QtrlyTrend
8
Latest Qtr: Dec2022
Quarterly Result Analysis →


POLY MEDICURE related INDICES

BSE Indices1W1M1Y
S&P BSE 500 1% -3.6% -1.7%
S&P BSE ALLCAP 0.9% -3.6% -1.7%
S&P BSE HEALTHCARE 0.5% -2.8% -10.9%
S&P BSE 250 SMALLCAP 0.2% -2.6% -0.9%
S&P BSE SMALL CAP 0% -3.1% -1.9%
NSE Indices1W1M1Y
NIFTY 500 1% -3.6% -1.8%
NIFTY500 MULTICAP 50:25:25 0.7% -3.3% -1.4%
NIFTY MID SMALL400 0.2% -2.6% 1.5%
NIFTY SMALLCAP250 0.1% -3.2% -4.4%

You may also like the below Video Courses


FAQ about POLY MEDICURE


Is POLY MEDICURE good for long term investment?

As on Mar 22,2023, the Fundamentals of POLY MEDICURE look Strong and hence it may be good for long term investment! See Financial Performance of POLY MEDICURE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is POLY MEDICURE UnderValued or OverValued?

As on Mar 22,2023, POLY MEDICURE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of POLY MEDICURE ?

As on Mar 22,2023, the Intrinsic Value of POLY MEDICURE is Rs. 313.80 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 287.67
Fair Value [Median EV / Sales Model] : Rs. 320.37
Fair Value [Median Price / Sales Model] : Rs. 313.80
Estimated Median Fair Value of POLY MEDICURE : Rs. 313.80

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is POLY MEDICURE trading at a Premium or Discount?

As on Mar 22,2023, POLY MEDICURE is trading at a Premium of 209% based on the estimates of Median Intrinsic Value!
Compare Stock Analytics with Peers
No other companies found in this Industry

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].